JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 25 No. 11 1204-1209
© 1984 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, S.-Y.
Right arrow Articles by Yu, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, S.-Y.
Right arrow Articles by Yu, A. C.

I-131 Total-Body Scan: Localization of Disseminated Gastric Adenocarcinoma. Case Report and Survey of the Literature

Sing-Yung Wu, Jozef Kollin, Eugene Coodley, Timothy Lockyer, Kenneth P. Lyons, Edgar Moran, Lawrence N. Parker and Albert C. Yu

Veterans Administration Medical Center, Long Beach
University of California, Irvine, California

Correspondence: For reprints contact: Sing-Yung Wu, MD, PhD, Nuclear Medicine Service, VA Medical Center, Long Beach, CA 90822.

ABSTRACT

This is a case of striking radioiodine and [99mTc]pertechnetate uptake by disseminated nonthyroidal (gastric) adenocarcinoma. A 65-yr-old man was euthyroid and serum thyroglobulin concentration was normal at 11 mg/ml. Bone-marrow biopsy showed that the metastatic tumor cells were negative for thyroglobulin on Immunoperoxidase stain and the secretory product was mucicarmine-positive. We estimate that radioiodine uptake in the normal thyroid gland was less than 10% of total tumor uptake. At autopsy, the stomach was the site of the primary tumor, which had the same cellular and histochemical characteristics as the metastatic lesions in bone and liver. It is emphasized that the use of pertechnetate for screening patients with gastric adenocarcinoma may be clinically useful in the early detection of metastatic lesions.




This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
N Nair, S Basu, and H Pakhale
Unusual uptake of radioiodine in the chest in a patient with thyroid carcinoma
Br. J. Radiol., January 1, 2004; 77(913): 63 - 67.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J.-K. Chung
Sodium Iodide Symporter: Its Role in Nuclear Medicine
J. Nucl. Med., September 1, 2002; 43(9): 1188 - 1200.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1984 by the Society of Nuclear Medicine.